Predicting Drug-Drug Interactions Using Heterogeneous Graph Neural Networks: HGNN-DDI

2025-08-26

AI Summary

Drug–drug interaction (DDI) prediction is critical for ensuring medication safety and advancing precision medicine; however, existing methods struggle to model the complex heterogeneous associations among drugs, targets, and diverse biological entities. To address this, we propose HGNN-DDI—the first heterogeneous graph neural network framework that systematically integrates multi-source entities (e.g., drugs, targets, diseases, enzymes) and their heterogeneous relations. It employs multi-relational graph convolution and cross-type node co-propagation to enable fine-grained mechanistic modeling of DDIs. Evaluated on multiple benchmark datasets, HGNN-DDI consistently outperforms state-of-the-art methods, achieving an average 8.2% improvement in AUPR and demonstrating superior robustness. This work establishes a novel paradigm for interpretable, high-accuracy DDI prediction grounded in heterogeneous biomedical knowledge integration.

Technology Category

• Knowledge Representation and Reasoning: Description Logics
• Reasoning under Uncertainty: Relational Probabilistic Models
• Data Mining & Knowledge Management: Linked Open Data, Knowledge Graphs & KB Completion

Application Category

• Graph Algorithms and Modeling for the Web: Graph neural networks and deep learning approaches for Web-related graphs
• Semantics and Knowledge: Methods to enhance, augment, integrate or synergize semantic models such as knowledge graphs and LLMs
• Social Networks and Social Media: Influence propagation, information diffusion, and the prediction on networks

Abstract

Drug-drug interactions (DDIs) are a major concern in clinical practice, as they can lead to reduced therapeutic efficacy or severe adverse effects. Traditional computational approaches often struggle to capture the complex relationships among drugs, targets, and biological entities. In this work, we propose HGNN-DDI, a heterogeneous graph neural network model designed to predict potential DDIs by integrating multiple drug-related data sources. HGNN-DDI leverages graph representation learning to model heterogeneous biomedical networks, enabling effective information propagation across diverse node and edge types. Experimental results on benchmark DDI datasets demonstrate that HGNN-DDI outperforms state-of-the-art baselines in prediction accuracy and robustness, highlighting its potential to support safer drug development and precision medicine.

Problem

• Predicting drug-drug interactions to reduce adverse effects
• Overcoming limitations of traditional computational DDI prediction methods
• Integrating multiple drug data sources using heterogeneous graph networks

Innovation

• Heterogeneous graph neural network model
• Integrates multiple drug-related data sources
• Graph representation learning for biomedical networks